Sacroiliac Joint Disruption

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Tenon Medical
Tenon MedicalLOS GATOS, CA
1 program
CATAMARAN SI Joint Fusion SystemN/A1 trial
Active Trials
NCT05633888Recruiting50Est. Jan 2026
SI-BONE
SI-BONESANTA CLARA, CA
1 program
iFuse 3-D in Bedrock ConfigurationN/A1 trial
Active Trials
NCT04062630CompletedEst. Jan 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Tenon MedicalCATAMARAN SI Joint Fusion System
SI-BONEiFuse 3-D in Bedrock Configuration

Clinical Trials (2)

Total enrollment: 50 patients across 2 trials

NCT05633888Tenon MedicalCATAMARAN SI Joint Fusion System

Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System

Start: Nov 2022Est. completion: Jan 202650 patients
N/ARecruiting
NCT04062630SI-BONEiFuse 3-D in Bedrock Configuration

SI Joint Stabilization in Long Fusion to the Pelvis

Start: May 2020Est. completion: Jan 2025
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 50 patients
2 companies competing in this space